Prostate specific antigen (PSA) is a biomarker of PCa, but its detection results are easily affected by drugs, inflammation and benign prostate lesions, especially lack of specificity and sensitivity in the early diagnosis and prediction of recurrence of PCa (8, 9). The gene discussed is KLK3; the disease is posterior cortical atrophy.